Dave Rushton
Founder
of Paradigm Shift Consulting Limited.
Dave Rushton is Founder of Paradigm Shift Consulting Limited, a Good Distribution Practice Consultancy.
Registered Office: Paradigm Shift Consulting Ltd,The Old Mill, 9 Soar Lane,Leicester, LE3 5DE, United Kingdom
0330 133 0920
In the world of pharmaceutical wholesale and distribution, compliance with EU GDP Guidelines, not least holding a valid WDA(H) licence, is essential.
Yet Paradigm Shift consultants have found that many businesses underestimate how much it costs, both in official fees and in practical time, preparation, and inspection costs.
Our previous Paradigm Shift post “How Much Will it Cost to Gain a WDA(H) aka Wholesale Dealers/Distribution Authorisation?” is now outdated. Here, we set out current figures (as of mid-2025), highlight what they cover, and show what pharmacies and wholesaler distributors need to budget for.
A WDA(H) is the licence you need in the UK if you are holding, supplying, or distributing human medicines.
It covers wholesale activities including supplying to other pharmaceutical wholesale distributors and persons authorised to dispense medicines to patients, importing from countries on an approved list, exporting, etc. WDA(H) activities differ depending upon the business model of the WDA(H) holder.
Pharmacies may need it if their activities extend beyond retail to the public, by supplying other legal entities, such as other pharmacies within their group or exporting outside of the UK.
The Medicines and Healthcare products Regulatory Agency (MHRA) also requires compliance with GDP (Good Distribution Practice), and there will be inspections as part of the process or on an ongoing risk basis.
Relying on previous WDA(H) and MHRA Inspection cost data can lead to significant under-budgeting.
It is recommended that you review the current costs as part of your annual budget planning to ensure you allocate the correct resources.
Below are the latest MHRA fees as of 2025 extracted from the MHRA.gov.uk website, relating to wholesale distribution authorisations, including standard applications, inspections, variations, etc.
| Type of Fee / Action | What it Covers / Conditions | Current Fee (£) |
| New Application – standard application + full inspection fee | For a full WDA(H) application, standard scope (licensed medicines, etc.), including inspection of the site | £6,295 (application fee £2,159 + inspection fee £4,136) |
| New Application – reduced application + full inspection fee | Reduced application (e.g. smaller scale, certain exemptions) but still full inspection | £5,128 (application fee £992 + inspection fee £4,136) |
| New Application – reduced application + reduced inspection fee (GSL only) | If dealing only with General Sales List (GSL) medicines | £3060 (application fee £992 + inspection fee £2,068) |
| New Application – change of ownership | Only relevant when the ownership of the WDA holder changes | £478 (no inspection) |
| WDA Variations | Changes to existing licences; fee depends on whether it is administrative or standard (technical), and whether inspection is needed | Standard variation: £583; Administrative variation: £309 |
| Inspections (periodic / per site / risk-based) | The site inspection fee when required; different rates apply depending on type of licence, product scope (e.g. GSL, homoeopathic, etc.) | Standard inspection (per site): £4,136; Reduced rate inspection fee: £2,068; THMP/Homeopathic only: £2,047; Reduced rate THMP/Homeopathic: £1,114 |
| Office-Based Risk Assessment | For some inspections / oversight where full site inspection is not needed, or risk-based assessments are possible. | £3,810 |
Please note: Special reduced rates apply to:
Pharmacies are in a special position. Many pharmacies do retail supply to the public, but under certain circumstances they also carry out wholesale/distribution activities (e.g. supplying other healthcare entities, NHS trusts, etc.).
Key considerations:
So, a registered pharmacy likely to distribute a limited range or small volumes might pay significantly less than the “standard” full-application cost. But the worst‐case or more complete wholesale operations should budget closer to the full application plus the standard inspection level.
GDP inspections are part of obtaining and maintaining a WDA(H) licence. In addition to the initial inspection as part of the WDA application process, periodic, risk-based inspections will also occur.
Following the initial application and inspection, there are ongoing or recurring costs to factor into your GDP operational budgets.
While the statutory fees are necessary, they are only part of the total cost.
Pharmacies and distributors need to budget also for:
From what our previous blog posts and others showed, the landscape has changed in the following ways:
More information relating to licensing can be found here.
Costs are dependent on your business model and the number of licence variation you may require, however, below is a rough estimate of what to expect:
Please keep in mind, when you add internal costs, upgrading facilities, ensuring compliance, remedial works after inspection, the “true cost” to a business may significantly exceed the MHRA fee component.
If you fail to prepare, prepare to fail! It is no longer a simple exercise to obtain a WDA(H), and the WDA(V) (veterinary medicine) is now also following the EU Guidelines of 2013, updated from following the 1994 regulations earlier in 2025.
If you used to work in wholesale years ago, or have an old set of SOPs you think are current, it is highly likely that you will receive a long post-inspection letter from your inspector, and they won’t like you very much and your risk profile will be higher, or you may be refused grant of the licence.
If you hire the wrong consultancy, for example one that is known for GMP, you may find yourself failing your MHRA inspection and covering the costs of a reinspection. This is very real and we have had customers come to us with this exact issue… who then asked us to resolve their issues for less than they paid the other, lesser consultancy.
If you are perceived to be a higher risk by the Inspectorate, you will have a shorter inspection schedule. If the inspectorate wish to visit every 6 months, you face a bill of over £8k per year. If it’s every 5 years it reduces to an average of £827.20 per year (Unless fees increase, of course).
Training is essential, for the Licence Holder (Body corporate, therefore anyone on Companies House), Responsible Person (regular CPD expected) and your operational personnel. If you are not skilled in wholesale activities, you should take external help. Depending where you go for training, your costs can be significant.
Paradigm Shift Consulting are the winners of the Pharma Industry Awards UK “Pharma Education and Training Award – 2025” for providing cost-effective, operational based training. Contact us or visit www.gdptraining.co.uk
Having untrained personnel handling potentially life saving medicines or controlled drugs can end in tragedy, and breaches of the Human Medicines Regulations 2012 (as amended) could result in a Licence Holder being imprisoned for up to two years, or suspension or revocation of your licence.
For pharmacies and pharmaceutical wholesale distributors considering applying for a WDA(H) licence, the MHRA fees in 2025 are significantly higher and more differentiated than they were a decade ago. A “standard” full-scope WDA(H) application with inspection is now £6,295, with reduced rates possible under certain conditions
GDP inspection costs, variation fees, change-of-ownership, and especially ongoing costs (annual service charge, compliance, remedial works) all add up.
Paradigm Shift Consulting Ltd offer a wide range of services and training to support you and your licence application, variation and retention.
We can:
In addition to the above we offer a wide range of award winning, CPD accredited GDP training courses, including:
We can also provide bespoke, tailored services and training for your organisation. Contact us for more information.